Skip to main content

Table 1 Baseline patients characteristics (N = 15)

From: Safety and efficacy of sirolimus in recurrent intravenous leiomyomatosis, pulmonary benign metastatic leiomyomatosis, and leiomyomatosis peritonealis disseminata: a pilot study

Characteristic

Patients (%)

Age, years, median (range)

46 (34–59)

ECOG performance status score

 0

12 (80.0)

 1

3 (20.0)

Disease

 Intravenous leiomyomatosis

5 (33.3)

 Pulmonary benign metastatic leiomyomatosis

8 (53.3)

 Leiomyomatosis peritonealis disseminata

2 (13.3)

Previous hysterectomy

 Yes

11 (73.3)

 No

4 (26.7)

Previous bilateral oophorectomy

 Yes

9 (60.0)

 No

6 (40.0)

  1. Abbreviation: ECOG, Eastern Cooperative Oncology Group